Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response
Background: Pulmonary arterial hypertension (PAH) is characterized by increased pulmonary vascular resistance, leading to right ventricular failure and death. Recent studies have suggested that chronic inflammatory processes are involved in the pathogenesis of PAH. Several studies have demonstrated...
Main Authors: | Jia-mei Yang, Ru Zhou, Min Zhang, Huan-ran Tan, Jian-qiang Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-05-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/23/6/1274 |
Similar Items
-
Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats
by: Yusheng Cheng, et al.
Published: (2018-08-01) -
Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
by: Yi Tong, et al.
Published: (2018-09-01) -
Comparative analysis of age in monocrotaline-induced pulmonary hypertensive rats
by: Akiko Kawade, et al.
Published: (2021-09-01) -
Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats
by: Chao Tang, et al.
Published: (2021-01-01) -
Arginase Inhibition Reverses Monocrotaline-Induced Pulmonary Hypertension
by: Christian Jung, et al.
Published: (2017-07-01)